2578
150
141
119
116
109
109
95
92
71
69
69
67
53
47
44
42
39
39
37
35
34
30
27
25
24
24
22
22
20
20
19
15
14
14
13
12
12
12
11
11
11
10
10
9
9
9
9
9
8
8
8
8
7
7
7
7
6
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
8349
834
389
38
3149
314
Lancet Oncol
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
PDF的下载单位、IP信息已删除
(2025-6-4)
DW
无极微光
cdercder
TE
牧青
Criminology34
学术文献互助
Enigma_GEB
科研狗
七颗茶香豆
Nole
Kao
渡人舟
OK
罗Eason
xing_xing
DOC_XIONG
秋风
zhixiang
null
皖公网安备34019202002308
